From Abdominal Adiposity to Hypertension: Mechanisms and Clinical Implications

1. Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968–77. 2. Hypertension Detection and Follow-Up Program Cooperative Group. Race, education and prevalence of hypertension. Am J Epidemol 1977;106:351–61. 3. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39–48. 4. Rocchini AP, Moorehead CP, DeRemer S, et al. Pathogenesis of weight-related changes in blood pressure in dogs. Hypertension 1989;13; 922–8. 5. Hall JE, Brands MW, Dixon WN, et al. Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension 1993;22:292–9. 6. Haynes R. Is weight loss an effective treatment for hypertension. Can J Physiol Pharmacol 1985;64:825. 7. Hypertension Prevention Treatment Group. The Hypertension Trial: Three-year effects of dietary changes on blood pressure. Arch Intern Med 1990;150:153. 9. Dornfield TP, Maxwell MH, Waks AU, et al. Obesity and Hypertension: Long-term effects of weight reduction on blood pressure. Intern J of Obesity 1985;9:381–9. 10. Sjostrom CD, Peltonen M, Sjostrom L. Blood pressure and pulse pressure during long-term weight loss in the obese: The Swedish Obese Subjects (SOS) Intervention Study. Obesity Res 2001;9:188–95. 11. Sironi AM, Pigitore A, Ghione S, et al. Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial and visceral fat. Hypertension 2008;51:1–7. 12. Verwaerde P, Denard JM, Galinier M, et al. Changes in short-term variability of blood pressure and heart rate during the development of obesity-associated hypertension in high—fat fed dogs. J Hypertens 1999;17:1135–43. 13. Mittelman SD, Van Citters GW, Kim SP, et al. Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced B-cell response. Diabetes 2000;49:2116–25. 14. Strazzullo P, Barbato A, Galletti F, et al. Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study. J Hypertension 2006; 24:1633–9. 15. Strazzullo P, Barba G, Cappuccio FP, et al. Altered renal sodium handling in men with abdominal adiposity, a link to hypertension. J Hypertens 2001;19:2157–64. 16. Barbato A, Cappuccio FP, Folkerd EJ, et al. Metabolic syndrome and renal sodium handling in three ethnic groups living in England. Diabetologia 2004;47:40–6. 17. Hall JE, Granger JP, Hester RL, et al. Mechanisms of sodium balance in hypertension: Role of pressure natriuresis. J Hypertens 1986;4(Suppl 4):S57–65. 18. Granger JP, West D, Scott J. Abnormal pressure natriuresis in the dog model of obesity-induced hypertension. Hypertension 1994;23(Suppl I):I8–11. 20. Rocchini AP, Moorehead C, DeRemer S, et al. Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension 1990;15:861–6. 21. Rocchini AP, Katch VL, Grekin R, et al. Role for aldosterone in blood pressure regulation of obese adolescents. Am J Cardiol 1986;57:613–8. 22. Goodfriend TL, Calhoun DA. Resistant hypertension, obesity, sleep apnea andaldosterone: theory and therapy. Hypertension 2004;43:518–24. 23. de Paula RB, da Silva AA, Hall JE. Aldosterone antagonism attenuates obesity-induced hypertension